Global Pharmaceutical Excipient Albumin Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Page: 102

Published Date: 31 Jan 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Related Reports
Product Tags

Description

According to our (Global Info Research) latest study, the global Pharmaceutical Excipient Albumin market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Albumin is a water-soluble globular protein produced in the liver. It accounts for 50% of blood plasma proteins. These play a vital role in regulating blood volume and act as transporters for molecules such as few hormones, bile salts, and ions. Albumin is commonly used as blood volumizer in rare diseases, burns, shocks, liver conditions, and other blood loss trauma and surgeries
This report is a detailed and comprehensive analysis for global Pharmaceutical Excipient Albumin market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:
Global Pharmaceutical Excipient Albumin market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Pharmaceutical Excipient Albumin market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Pharmaceutical Excipient Albumin market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Pharmaceutical Excipient Albumin market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Pharmaceutical Excipient Albumin
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Pharmaceutical Excipient Albumin market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include CSL, Grifols, Takeda, Octapharma and Hualan Bio, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market Segmentation
Pharmaceutical Excipient Albumin market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    Human Serum Albumin
    Recombinant Albumin

Market segment by Application
    Cell Culture Media
    Medical Supplements

Major players covered
    CSL
    Grifols
    Takeda
    Octapharma
    Hualan Bio
    CBPO
    Shanghai RAAS
    Kedrion
    LFB Group
    Albumedix
    Biotest
    Merck
    Ventria (InVitria)
    HiMedia

Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Pharmaceutical Excipient Albumin product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Pharmaceutical Excipient Albumin, with price, sales, revenue and global market share of Pharmaceutical Excipient Albumin from 2018 to 2023.
Chapter 3, the Pharmaceutical Excipient Albumin competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Pharmaceutical Excipient Albumin breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Pharmaceutical Excipient Albumin market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Pharmaceutical Excipient Albumin.
Chapter 14 and 15, to describe Pharmaceutical Excipient Albumin sales channel, distributors, customers, research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Pharmaceutical Excipient Albumin
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global Pharmaceutical Excipient Albumin Consumption Value by Type: 2018 Versus 2022 Versus 2029
        1.3.2 Human Serum Albumin
        1.3.3 Recombinant Albumin
    1.4 Market Analysis by Application
        1.4.1 Overview: Global Pharmaceutical Excipient Albumin Consumption Value by Application: 2018 Versus 2022 Versus 2029
        1.4.2 Cell Culture Media
        1.4.3 Medical Supplements
    1.5 Global Pharmaceutical Excipient Albumin Market Size & Forecast
        1.5.1 Global Pharmaceutical Excipient Albumin Consumption Value (2018 & 2022 & 2029)
        1.5.2 Global Pharmaceutical Excipient Albumin Sales Quantity (2018-2029)
        1.5.3 Global Pharmaceutical Excipient Albumin Average Price (2018-2029)

2 Manufacturers Profiles
    2.1 CSL
        2.1.1 CSL Details
        2.1.2 CSL Major Business
        2.1.3 CSL Pharmaceutical Excipient Albumin Product and Services
        2.1.4 CSL Pharmaceutical Excipient Albumin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 CSL Recent Developments/Updates
    2.2 Grifols
        2.2.1 Grifols Details
        2.2.2 Grifols Major Business
        2.2.3 Grifols Pharmaceutical Excipient Albumin Product and Services
        2.2.4 Grifols Pharmaceutical Excipient Albumin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 Grifols Recent Developments/Updates
    2.3 Takeda
        2.3.1 Takeda Details
        2.3.2 Takeda Major Business
        2.3.3 Takeda Pharmaceutical Excipient Albumin Product and Services
        2.3.4 Takeda Pharmaceutical Excipient Albumin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 Takeda Recent Developments/Updates
    2.4 Octapharma
        2.4.1 Octapharma Details
        2.4.2 Octapharma Major Business
        2.4.3 Octapharma Pharmaceutical Excipient Albumin Product and Services
        2.4.4 Octapharma Pharmaceutical Excipient Albumin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 Octapharma Recent Developments/Updates
    2.5 Hualan Bio
        2.5.1 Hualan Bio Details
        2.5.2 Hualan Bio Major Business
        2.5.3 Hualan Bio Pharmaceutical Excipient Albumin Product and Services
        2.5.4 Hualan Bio Pharmaceutical Excipient Albumin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 Hualan Bio Recent Developments/Updates
    2.6 CBPO
        2.6.1 CBPO Details
        2.6.2 CBPO Major Business
        2.6.3 CBPO Pharmaceutical Excipient Albumin Product and Services
        2.6.4 CBPO Pharmaceutical Excipient Albumin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.6.5 CBPO Recent Developments/Updates
    2.7 Shanghai RAAS
        2.7.1 Shanghai RAAS Details
        2.7.2 Shanghai RAAS Major Business
        2.7.3 Shanghai RAAS Pharmaceutical Excipient Albumin Product and Services
        2.7.4 Shanghai RAAS Pharmaceutical Excipient Albumin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.7.5 Shanghai RAAS Recent Developments/Updates
    2.8 Kedrion
        2.8.1 Kedrion Details
        2.8.2 Kedrion Major Business
        2.8.3 Kedrion Pharmaceutical Excipient Albumin Product and Services
        2.8.4 Kedrion Pharmaceutical Excipient Albumin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.8.5 Kedrion Recent Developments/Updates
    2.9 LFB Group
        2.9.1 LFB Group Details
        2.9.2 LFB Group Major Business
        2.9.3 LFB Group Pharmaceutical Excipient Albumin Product and Services
        2.9.4 LFB Group Pharmaceutical Excipient Albumin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.9.5 LFB Group Recent Developments/Updates
    2.10 Albumedix
        2.10.1 Albumedix Details
        2.10.2 Albumedix Major Business
        2.10.3 Albumedix Pharmaceutical Excipient Albumin Product and Services
        2.10.4 Albumedix Pharmaceutical Excipient Albumin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.10.5 Albumedix Recent Developments/Updates
    2.11 Biotest
        2.11.1 Biotest Details
        2.11.2 Biotest Major Business
        2.11.3 Biotest Pharmaceutical Excipient Albumin Product and Services
        2.11.4 Biotest Pharmaceutical Excipient Albumin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.11.5 Biotest Recent Developments/Updates
    2.12 Merck
        2.12.1 Merck Details
        2.12.2 Merck Major Business
        2.12.3 Merck Pharmaceutical Excipient Albumin Product and Services
        2.12.4 Merck Pharmaceutical Excipient Albumin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.12.5 Merck Recent Developments/Updates
    2.13 Ventria (InVitria)
        2.13.1 Ventria (InVitria) Details
        2.13.2 Ventria (InVitria) Major Business
        2.13.3 Ventria (InVitria) Pharmaceutical Excipient Albumin Product and Services
        2.13.4 Ventria (InVitria) Pharmaceutical Excipient Albumin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.13.5 Ventria (InVitria) Recent Developments/Updates
    2.14 HiMedia
        2.14.1 HiMedia Details
        2.14.2 HiMedia Major Business
        2.14.3 HiMedia Pharmaceutical Excipient Albumin Product and Services
        2.14.4 HiMedia Pharmaceutical Excipient Albumin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.14.5 HiMedia Recent Developments/Updates

3 Competitive Environment: Pharmaceutical Excipient Albumin by Manufacturer
    3.1 Global Pharmaceutical Excipient Albumin Sales Quantity by Manufacturer (2018-2023)
    3.2 Global Pharmaceutical Excipient Albumin Revenue by Manufacturer (2018-2023)
    3.3 Global Pharmaceutical Excipient Albumin Average Price by Manufacturer (2018-2023)
    3.4 Market Share Analysis (2022)
        3.4.1 Producer Shipments of Pharmaceutical Excipient Albumin by Manufacturer Revenue ($MM) and Market Share (%): 2022
        3.4.2 Top 3 Pharmaceutical Excipient Albumin Manufacturer Market Share in 2022
        3.4.2 Top 6 Pharmaceutical Excipient Albumin Manufacturer Market Share in 2022
    3.5 Pharmaceutical Excipient Albumin Market: Overall Company Footprint Analysis
        3.5.1 Pharmaceutical Excipient Albumin Market: Region Footprint
        3.5.2 Pharmaceutical Excipient Albumin Market: Company Product Type Footprint
        3.5.3 Pharmaceutical Excipient Albumin Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
    4.1 Global Pharmaceutical Excipient Albumin Market Size by Region
        4.1.1 Global Pharmaceutical Excipient Albumin Sales Quantity by Region (2018-2029)
        4.1.2 Global Pharmaceutical Excipient Albumin Consumption Value by Region (2018-2029)
        4.1.3 Global Pharmaceutical Excipient Albumin Average Price by Region (2018-2029)
    4.2 North America Pharmaceutical Excipient Albumin Consumption Value (2018-2029)
    4.3 Europe Pharmaceutical Excipient Albumin Consumption Value (2018-2029)
    4.4 Asia-Pacific Pharmaceutical Excipient Albumin Consumption Value (2018-2029)
    4.5 South America Pharmaceutical Excipient Albumin Consumption Value (2018-2029)
    4.6 Middle East and Africa Pharmaceutical Excipient Albumin Consumption Value (2018-2029)

5 Market Segment by Type
    5.1 Global Pharmaceutical Excipient Albumin Sales Quantity by Type (2018-2029)
    5.2 Global Pharmaceutical Excipient Albumin Consumption Value by Type (2018-2029)
    5.3 Global Pharmaceutical Excipient Albumin Average Price by Type (2018-2029)

6 Market Segment by Application
    6.1 Global Pharmaceutical Excipient Albumin Sales Quantity by Application (2018-2029)
    6.2 Global Pharmaceutical Excipient Albumin Consumption Value by Application (2018-2029)
    6.3 Global Pharmaceutical Excipient Albumin Average Price by Application (2018-2029)

7 North America
    7.1 North America Pharmaceutical Excipient Albumin Sales Quantity by Type (2018-2029)
    7.2 North America Pharmaceutical Excipient Albumin Sales Quantity by Application (2018-2029)
    7.3 North America Pharmaceutical Excipient Albumin Market Size by Country
        7.3.1 North America Pharmaceutical Excipient Albumin Sales Quantity by Country (2018-2029)
        7.3.2 North America Pharmaceutical Excipient Albumin Consumption Value by Country (2018-2029)
        7.3.3 United States Market Size and Forecast (2018-2029)
        7.3.4 Canada Market Size and Forecast (2018-2029)
        7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe
    8.1 Europe Pharmaceutical Excipient Albumin Sales Quantity by Type (2018-2029)
    8.2 Europe Pharmaceutical Excipient Albumin Sales Quantity by Application (2018-2029)
    8.3 Europe Pharmaceutical Excipient Albumin Market Size by Country
        8.3.1 Europe Pharmaceutical Excipient Albumin Sales Quantity by Country (2018-2029)
        8.3.2 Europe Pharmaceutical Excipient Albumin Consumption Value by Country (2018-2029)
        8.3.3 Germany Market Size and Forecast (2018-2029)
        8.3.4 France Market Size and Forecast (2018-2029)
        8.3.5 United Kingdom Market Size and Forecast (2018-2029)
        8.3.6 Russia Market Size and Forecast (2018-2029)
        8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific
    9.1 Asia-Pacific Pharmaceutical Excipient Albumin Sales Quantity by Type (2018-2029)
    9.2 Asia-Pacific Pharmaceutical Excipient Albumin Sales Quantity by Application (2018-2029)
    9.3 Asia-Pacific Pharmaceutical Excipient Albumin Market Size by Region
        9.3.1 Asia-Pacific Pharmaceutical Excipient Albumin Sales Quantity by Region (2018-2029)
        9.3.2 Asia-Pacific Pharmaceutical Excipient Albumin Consumption Value by Region (2018-2029)
        9.3.3 China Market Size and Forecast (2018-2029)
        9.3.4 Japan Market Size and Forecast (2018-2029)
        9.3.5 Korea Market Size and Forecast (2018-2029)
        9.3.6 India Market Size and Forecast (2018-2029)
        9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
        9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America
    10.1 South America Pharmaceutical Excipient Albumin Sales Quantity by Type (2018-2029)
    10.2 South America Pharmaceutical Excipient Albumin Sales Quantity by Application (2018-2029)
    10.3 South America Pharmaceutical Excipient Albumin Market Size by Country
        10.3.1 South America Pharmaceutical Excipient Albumin Sales Quantity by Country (2018-2029)
        10.3.2 South America Pharmaceutical Excipient Albumin Consumption Value by Country (2018-2029)
        10.3.3 Brazil Market Size and Forecast (2018-2029)
        10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa
    11.1 Middle East & Africa Pharmaceutical Excipient Albumin Sales Quantity by Type (2018-2029)
    11.2 Middle East & Africa Pharmaceutical Excipient Albumin Sales Quantity by Application (2018-2029)
    11.3 Middle East & Africa Pharmaceutical Excipient Albumin Market Size by Country
        11.3.1 Middle East & Africa Pharmaceutical Excipient Albumin Sales Quantity by Country (2018-2029)
        11.3.2 Middle East & Africa Pharmaceutical Excipient Albumin Consumption Value by Country (2018-2029)
        11.3.3 Turkey Market Size and Forecast (2018-2029)
        11.3.4 Egypt Market Size and Forecast (2018-2029)
        11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
        11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics
    12.1 Pharmaceutical Excipient Albumin Market Drivers
    12.2 Pharmaceutical Excipient Albumin Market Restraints
    12.3 Pharmaceutical Excipient Albumin Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry
    12.5 Influence of COVID-19 and Russia-Ukraine War
        12.5.1 Influence of COVID-19
        12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain
    13.1 Raw Material of Pharmaceutical Excipient Albumin and Key Manufacturers
    13.2 Manufacturing Costs Percentage of Pharmaceutical Excipient Albumin
    13.3 Pharmaceutical Excipient Albumin Production Process
    13.4 Pharmaceutical Excipient Albumin Industrial Chain

14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 Pharmaceutical Excipient Albumin Typical Distributors
    14.3 Pharmaceutical Excipient Albumin Typical Customers

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Pharmaceutical Excipient Albumin Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 2. Global Pharmaceutical Excipient Albumin Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 3. CSL Basic Information, Manufacturing Base and Competitors
    Table 4. CSL Major Business
    Table 5. CSL Pharmaceutical Excipient Albumin Product and Services
    Table 6. CSL Pharmaceutical Excipient Albumin Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 7. CSL Recent Developments/Updates
    Table 8. Grifols Basic Information, Manufacturing Base and Competitors
    Table 9. Grifols Major Business
    Table 10. Grifols Pharmaceutical Excipient Albumin Product and Services
    Table 11. Grifols Pharmaceutical Excipient Albumin Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 12. Grifols Recent Developments/Updates
    Table 13. Takeda Basic Information, Manufacturing Base and Competitors
    Table 14. Takeda Major Business
    Table 15. Takeda Pharmaceutical Excipient Albumin Product and Services
    Table 16. Takeda Pharmaceutical Excipient Albumin Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 17. Takeda Recent Developments/Updates
    Table 18. Octapharma Basic Information, Manufacturing Base and Competitors
    Table 19. Octapharma Major Business
    Table 20. Octapharma Pharmaceutical Excipient Albumin Product and Services
    Table 21. Octapharma Pharmaceutical Excipient Albumin Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 22. Octapharma Recent Developments/Updates
    Table 23. Hualan Bio Basic Information, Manufacturing Base and Competitors
    Table 24. Hualan Bio Major Business
    Table 25. Hualan Bio Pharmaceutical Excipient Albumin Product and Services
    Table 26. Hualan Bio Pharmaceutical Excipient Albumin Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 27. Hualan Bio Recent Developments/Updates
    Table 28. CBPO Basic Information, Manufacturing Base and Competitors
    Table 29. CBPO Major Business
    Table 30. CBPO Pharmaceutical Excipient Albumin Product and Services
    Table 31. CBPO Pharmaceutical Excipient Albumin Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 32. CBPO Recent Developments/Updates
    Table 33. Shanghai RAAS Basic Information, Manufacturing Base and Competitors
    Table 34. Shanghai RAAS Major Business
    Table 35. Shanghai RAAS Pharmaceutical Excipient Albumin Product and Services
    Table 36. Shanghai RAAS Pharmaceutical Excipient Albumin Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 37. Shanghai RAAS Recent Developments/Updates
    Table 38. Kedrion Basic Information, Manufacturing Base and Competitors
    Table 39. Kedrion Major Business
    Table 40. Kedrion Pharmaceutical Excipient Albumin Product and Services
    Table 41. Kedrion Pharmaceutical Excipient Albumin Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 42. Kedrion Recent Developments/Updates
    Table 43. LFB Group Basic Information, Manufacturing Base and Competitors
    Table 44. LFB Group Major Business
    Table 45. LFB Group Pharmaceutical Excipient Albumin Product and Services
    Table 46. LFB Group Pharmaceutical Excipient Albumin Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 47. LFB Group Recent Developments/Updates
    Table 48. Albumedix Basic Information, Manufacturing Base and Competitors
    Table 49. Albumedix Major Business
    Table 50. Albumedix Pharmaceutical Excipient Albumin Product and Services
    Table 51. Albumedix Pharmaceutical Excipient Albumin Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 52. Albumedix Recent Developments/Updates
    Table 53. Biotest Basic Information, Manufacturing Base and Competitors
    Table 54. Biotest Major Business
    Table 55. Biotest Pharmaceutical Excipient Albumin Product and Services
    Table 56. Biotest Pharmaceutical Excipient Albumin Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 57. Biotest Recent Developments/Updates
    Table 58. Merck Basic Information, Manufacturing Base and Competitors
    Table 59. Merck Major Business
    Table 60. Merck Pharmaceutical Excipient Albumin Product and Services
    Table 61. Merck Pharmaceutical Excipient Albumin Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 62. Merck Recent Developments/Updates
    Table 63. Ventria (InVitria) Basic Information, Manufacturing Base and Competitors
    Table 64. Ventria (InVitria) Major Business
    Table 65. Ventria (InVitria) Pharmaceutical Excipient Albumin Product and Services
    Table 66. Ventria (InVitria) Pharmaceutical Excipient Albumin Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 67. Ventria (InVitria) Recent Developments/Updates
    Table 68. HiMedia Basic Information, Manufacturing Base and Competitors
    Table 69. HiMedia Major Business
    Table 70. HiMedia Pharmaceutical Excipient Albumin Product and Services
    Table 71. HiMedia Pharmaceutical Excipient Albumin Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 72. HiMedia Recent Developments/Updates
    Table 73. Global Pharmaceutical Excipient Albumin Sales Quantity by Manufacturer (2018-2023) & (K Units)
    Table 74. Global Pharmaceutical Excipient Albumin Revenue by Manufacturer (2018-2023) & (USD Million)
    Table 75. Global Pharmaceutical Excipient Albumin Average Price by Manufacturer (2018-2023) & (US$/Unit)
    Table 76. Market Position of Manufacturers in Pharmaceutical Excipient Albumin, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
    Table 77. Head Office and Pharmaceutical Excipient Albumin Production Site of Key Manufacturer
    Table 78. Pharmaceutical Excipient Albumin Market: Company Product Type Footprint
    Table 79. Pharmaceutical Excipient Albumin Market: Company Product Application Footprint
    Table 80. Pharmaceutical Excipient Albumin New Market Entrants and Barriers to Market Entry
    Table 81. Pharmaceutical Excipient Albumin Mergers, Acquisition, Agreements, and Collaborations
    Table 82. Global Pharmaceutical Excipient Albumin Sales Quantity by Region (2018-2023) & (K Units)
    Table 83. Global Pharmaceutical Excipient Albumin Sales Quantity by Region (2024-2029) & (K Units)
    Table 84. Global Pharmaceutical Excipient Albumin Consumption Value by Region (2018-2023) & (USD Million)
    Table 85. Global Pharmaceutical Excipient Albumin Consumption Value by Region (2024-2029) & (USD Million)
    Table 86. Global Pharmaceutical Excipient Albumin Average Price by Region (2018-2023) & (US$/Unit)
    Table 87. Global Pharmaceutical Excipient Albumin Average Price by Region (2024-2029) & (US$/Unit)
    Table 88. Global Pharmaceutical Excipient Albumin Sales Quantity by Type (2018-2023) & (K Units)
    Table 89. Global Pharmaceutical Excipient Albumin Sales Quantity by Type (2024-2029) & (K Units)
    Table 90. Global Pharmaceutical Excipient Albumin Consumption Value by Type (2018-2023) & (USD Million)
    Table 91. Global Pharmaceutical Excipient Albumin Consumption Value by Type (2024-2029) & (USD Million)
    Table 92. Global Pharmaceutical Excipient Albumin Average Price by Type (2018-2023) & (US$/Unit)
    Table 93. Global Pharmaceutical Excipient Albumin Average Price by Type (2024-2029) & (US$/Unit)
    Table 94. Global Pharmaceutical Excipient Albumin Sales Quantity by Application (2018-2023) & (K Units)
    Table 95. Global Pharmaceutical Excipient Albumin Sales Quantity by Application (2024-2029) & (K Units)
    Table 96. Global Pharmaceutical Excipient Albumin Consumption Value by Application (2018-2023) & (USD Million)
    Table 97. Global Pharmaceutical Excipient Albumin Consumption Value by Application (2024-2029) & (USD Million)
    Table 98. Global Pharmaceutical Excipient Albumin Average Price by Application (2018-2023) & (US$/Unit)
    Table 99. Global Pharmaceutical Excipient Albumin Average Price by Application (2024-2029) & (US$/Unit)
    Table 100. North America Pharmaceutical Excipient Albumin Sales Quantity by Type (2018-2023) & (K Units)
    Table 101. North America Pharmaceutical Excipient Albumin Sales Quantity by Type (2024-2029) & (K Units)
    Table 102. North America Pharmaceutical Excipient Albumin Sales Quantity by Application (2018-2023) & (K Units)
    Table 103. North America Pharmaceutical Excipient Albumin Sales Quantity by Application (2024-2029) & (K Units)
    Table 104. North America Pharmaceutical Excipient Albumin Sales Quantity by Country (2018-2023) & (K Units)
    Table 105. North America Pharmaceutical Excipient Albumin Sales Quantity by Country (2024-2029) & (K Units)
    Table 106. North America Pharmaceutical Excipient Albumin Consumption Value by Country (2018-2023) & (USD Million)
    Table 107. North America Pharmaceutical Excipient Albumin Consumption Value by Country (2024-2029) & (USD Million)
    Table 108. Europe Pharmaceutical Excipient Albumin Sales Quantity by Type (2018-2023) & (K Units)
    Table 109. Europe Pharmaceutical Excipient Albumin Sales Quantity by Type (2024-2029) & (K Units)
    Table 110. Europe Pharmaceutical Excipient Albumin Sales Quantity by Application (2018-2023) & (K Units)
    Table 111. Europe Pharmaceutical Excipient Albumin Sales Quantity by Application (2024-2029) & (K Units)
    Table 112. Europe Pharmaceutical Excipient Albumin Sales Quantity by Country (2018-2023) & (K Units)
    Table 113. Europe Pharmaceutical Excipient Albumin Sales Quantity by Country (2024-2029) & (K Units)
    Table 114. Europe Pharmaceutical Excipient Albumin Consumption Value by Country (2018-2023) & (USD Million)
    Table 115. Europe Pharmaceutical Excipient Albumin Consumption Value by Country (2024-2029) & (USD Million)
    Table 116. Asia-Pacific Pharmaceutical Excipient Albumin Sales Quantity by Type (2018-2023) & (K Units)
    Table 117. Asia-Pacific Pharmaceutical Excipient Albumin Sales Quantity by Type (2024-2029) & (K Units)
    Table 118. Asia-Pacific Pharmaceutical Excipient Albumin Sales Quantity by Application (2018-2023) & (K Units)
    Table 119. Asia-Pacific Pharmaceutical Excipient Albumin Sales Quantity by Application (2024-2029) & (K Units)
    Table 120. Asia-Pacific Pharmaceutical Excipient Albumin Sales Quantity by Region (2018-2023) & (K Units)
    Table 121. Asia-Pacific Pharmaceutical Excipient Albumin Sales Quantity by Region (2024-2029) & (K Units)
    Table 122. Asia-Pacific Pharmaceutical Excipient Albumin Consumption Value by Region (2018-2023) & (USD Million)
    Table 123. Asia-Pacific Pharmaceutical Excipient Albumin Consumption Value by Region (2024-2029) & (USD Million)
    Table 124. South America Pharmaceutical Excipient Albumin Sales Quantity by Type (2018-2023) & (K Units)
    Table 125. South America Pharmaceutical Excipient Albumin Sales Quantity by Type (2024-2029) & (K Units)
    Table 126. South America Pharmaceutical Excipient Albumin Sales Quantity by Application (2018-2023) & (K Units)
    Table 127. South America Pharmaceutical Excipient Albumin Sales Quantity by Application (2024-2029) & (K Units)
    Table 128. South America Pharmaceutical Excipient Albumin Sales Quantity by Country (2018-2023) & (K Units)
    Table 129. South America Pharmaceutical Excipient Albumin Sales Quantity by Country (2024-2029) & (K Units)
    Table 130. South America Pharmaceutical Excipient Albumin Consumption Value by Country (2018-2023) & (USD Million)
    Table 131. South America Pharmaceutical Excipient Albumin Consumption Value by Country (2024-2029) & (USD Million)
    Table 132. Middle East & Africa Pharmaceutical Excipient Albumin Sales Quantity by Type (2018-2023) & (K Units)
    Table 133. Middle East & Africa Pharmaceutical Excipient Albumin Sales Quantity by Type (2024-2029) & (K Units)
    Table 134. Middle East & Africa Pharmaceutical Excipient Albumin Sales Quantity by Application (2018-2023) & (K Units)
    Table 135. Middle East & Africa Pharmaceutical Excipient Albumin Sales Quantity by Application (2024-2029) & (K Units)
    Table 136. Middle East & Africa Pharmaceutical Excipient Albumin Sales Quantity by Region (2018-2023) & (K Units)
    Table 137. Middle East & Africa Pharmaceutical Excipient Albumin Sales Quantity by Region (2024-2029) & (K Units)
    Table 138. Middle East & Africa Pharmaceutical Excipient Albumin Consumption Value by Region (2018-2023) & (USD Million)
    Table 139. Middle East & Africa Pharmaceutical Excipient Albumin Consumption Value by Region (2024-2029) & (USD Million)
    Table 140. Pharmaceutical Excipient Albumin Raw Material
    Table 141. Key Manufacturers of Pharmaceutical Excipient Albumin Raw Materials
    Table 142. Pharmaceutical Excipient Albumin Typical Distributors
    Table 143. Pharmaceutical Excipient Albumin Typical Customers
List of Figures
    Figure 1. Pharmaceutical Excipient Albumin Picture
    Figure 2. Global Pharmaceutical Excipient Albumin Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 3. Global Pharmaceutical Excipient Albumin Consumption Value Market Share by Type in 2022
    Figure 4. Human Serum Albumin Examples
    Figure 5. Recombinant Albumin Examples
    Figure 6. Global Pharmaceutical Excipient Albumin Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Figure 7. Global Pharmaceutical Excipient Albumin Consumption Value Market Share by Application in 2022
    Figure 8. Cell Culture Media Examples
    Figure 9. Medical Supplements Examples
    Figure 10. Global Pharmaceutical Excipient Albumin Consumption Value, (USD Million): 2018 & 2022 & 2029
    Figure 11. Global Pharmaceutical Excipient Albumin Consumption Value and Forecast (2018-2029) & (USD Million)
    Figure 12. Global Pharmaceutical Excipient Albumin Sales Quantity (2018-2029) & (K Units)
    Figure 13. Global Pharmaceutical Excipient Albumin Average Price (2018-2029) & (US$/Unit)
    Figure 14. Global Pharmaceutical Excipient Albumin Sales Quantity Market Share by Manufacturer in 2022
    Figure 15. Global Pharmaceutical Excipient Albumin Consumption Value Market Share by Manufacturer in 2022
    Figure 16. Producer Shipments of Pharmaceutical Excipient Albumin by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
    Figure 17. Top 3 Pharmaceutical Excipient Albumin Manufacturer (Consumption Value) Market Share in 2022
    Figure 18. Top 6 Pharmaceutical Excipient Albumin Manufacturer (Consumption Value) Market Share in 2022
    Figure 19. Global Pharmaceutical Excipient Albumin Sales Quantity Market Share by Region (2018-2029)
    Figure 20. Global Pharmaceutical Excipient Albumin Consumption Value Market Share by Region (2018-2029)
    Figure 21. North America Pharmaceutical Excipient Albumin Consumption Value (2018-2029) & (USD Million)
    Figure 22. Europe Pharmaceutical Excipient Albumin Consumption Value (2018-2029) & (USD Million)
    Figure 23. Asia-Pacific Pharmaceutical Excipient Albumin Consumption Value (2018-2029) & (USD Million)
    Figure 24. South America Pharmaceutical Excipient Albumin Consumption Value (2018-2029) & (USD Million)
    Figure 25. Middle East & Africa Pharmaceutical Excipient Albumin Consumption Value (2018-2029) & (USD Million)
    Figure 26. Global Pharmaceutical Excipient Albumin Sales Quantity Market Share by Type (2018-2029)
    Figure 27. Global Pharmaceutical Excipient Albumin Consumption Value Market Share by Type (2018-2029)
    Figure 28. Global Pharmaceutical Excipient Albumin Average Price by Type (2018-2029) & (US$/Unit)
    Figure 29. Global Pharmaceutical Excipient Albumin Sales Quantity Market Share by Application (2018-2029)
    Figure 30. Global Pharmaceutical Excipient Albumin Consumption Value Market Share by Application (2018-2029)
    Figure 31. Global Pharmaceutical Excipient Albumin Average Price by Application (2018-2029) & (US$/Unit)
    Figure 32. North America Pharmaceutical Excipient Albumin Sales Quantity Market Share by Type (2018-2029)
    Figure 33. North America Pharmaceutical Excipient Albumin Sales Quantity Market Share by Application (2018-2029)
    Figure 34. North America Pharmaceutical Excipient Albumin Sales Quantity Market Share by Country (2018-2029)
    Figure 35. North America Pharmaceutical Excipient Albumin Consumption Value Market Share by Country (2018-2029)
    Figure 36. United States Pharmaceutical Excipient Albumin Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 37. Canada Pharmaceutical Excipient Albumin Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 38. Mexico Pharmaceutical Excipient Albumin Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 39. Europe Pharmaceutical Excipient Albumin Sales Quantity Market Share by Type (2018-2029)
    Figure 40. Europe Pharmaceutical Excipient Albumin Sales Quantity Market Share by Application (2018-2029)
    Figure 41. Europe Pharmaceutical Excipient Albumin Sales Quantity Market Share by Country (2018-2029)
    Figure 42. Europe Pharmaceutical Excipient Albumin Consumption Value Market Share by Country (2018-2029)
    Figure 43. Germany Pharmaceutical Excipient Albumin Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 44. France Pharmaceutical Excipient Albumin Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 45. United Kingdom Pharmaceutical Excipient Albumin Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 46. Russia Pharmaceutical Excipient Albumin Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 47. Italy Pharmaceutical Excipient Albumin Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 48. Asia-Pacific Pharmaceutical Excipient Albumin Sales Quantity Market Share by Type (2018-2029)
    Figure 49. Asia-Pacific Pharmaceutical Excipient Albumin Sales Quantity Market Share by Application (2018-2029)
    Figure 50. Asia-Pacific Pharmaceutical Excipient Albumin Sales Quantity Market Share by Region (2018-2029)
    Figure 51. Asia-Pacific Pharmaceutical Excipient Albumin Consumption Value Market Share by Region (2018-2029)
    Figure 52. China Pharmaceutical Excipient Albumin Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 53. Japan Pharmaceutical Excipient Albumin Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 54. Korea Pharmaceutical Excipient Albumin Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 55. India Pharmaceutical Excipient Albumin Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 56. Southeast Asia Pharmaceutical Excipient Albumin Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 57. Australia Pharmaceutical Excipient Albumin Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 58. South America Pharmaceutical Excipient Albumin Sales Quantity Market Share by Type (2018-2029)
    Figure 59. South America Pharmaceutical Excipient Albumin Sales Quantity Market Share by Application (2018-2029)
    Figure 60. South America Pharmaceutical Excipient Albumin Sales Quantity Market Share by Country (2018-2029)
    Figure 61. South America Pharmaceutical Excipient Albumin Consumption Value Market Share by Country (2018-2029)
    Figure 62. Brazil Pharmaceutical Excipient Albumin Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 63. Argentina Pharmaceutical Excipient Albumin Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 64. Middle East & Africa Pharmaceutical Excipient Albumin Sales Quantity Market Share by Type (2018-2029)
    Figure 65. Middle East & Africa Pharmaceutical Excipient Albumin Sales Quantity Market Share by Application (2018-2029)
    Figure 66. Middle East & Africa Pharmaceutical Excipient Albumin Sales Quantity Market Share by Region (2018-2029)
    Figure 67. Middle East & Africa Pharmaceutical Excipient Albumin Consumption Value Market Share by Region (2018-2029)
    Figure 68. Turkey Pharmaceutical Excipient Albumin Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 69. Egypt Pharmaceutical Excipient Albumin Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 70. Saudi Arabia Pharmaceutical Excipient Albumin Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 71. South Africa Pharmaceutical Excipient Albumin Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 72. Pharmaceutical Excipient Albumin Market Drivers
    Figure 73. Pharmaceutical Excipient Albumin Market Restraints
    Figure 74. Pharmaceutical Excipient Albumin Market Trends
    Figure 75. Porters Five Forces Analysis
    Figure 76. Manufacturing Cost Structure Analysis of Pharmaceutical Excipient Albumin in 2022
    Figure 77. Manufacturing Process Analysis of Pharmaceutical Excipient Albumin
    Figure 78. Pharmaceutical Excipient Albumin Industrial Chain
    Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
    Figure 80. Direct Channel Pros & Cons
    Figure 81. Indirect Channel Pros & Cons
    Figure 82. Methodology
    Figure 83. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Related Reports

Global Pharmaceutical Excipient Albumin Supply, Demand and Key Producers, 2023-2029

Global Pharmaceutical Excipient Albumin Supply, Demand and Key Producers, 2023-2029

date 31 Jan 2023

date Pharma & Healthcare

The global Pharmaceutical Excipient Albumin market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Global Pharmaceutical Excipient Albumin Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Pharmaceutical Excipient Albumin Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 11 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Pharmaceutical Excipient Albumin market size was valued at USD 735.7 million in 2023 and is forecast to a readjusted size of USD 1233 million by 2030 with a CAGR of 7.7% during review period.

Global Pharmaceutical Excipient Albumin Supply, Demand and Key Producers, 2024-2030

Global Pharmaceutical Excipient Albumin Supply, Demand and Key Producers, 2024-2030

date 14 Feb 2024

date Pharma & Healthcare

The global Pharmaceutical Excipient Albumin market size is expected to reach $ 1233 million by 2030, rising at a market growth of 7.7% CAGR during the forecast period (2024-2030).

Product Tags

Pharmaceutical Excipient Albumin

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>